{"disease":{"id":"atezolizumab-bevacizumab","name":"atezolizumab bevacizumab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07495735","title":"Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT05763277","title":"Ate-Bev Early Response Prediction Model in Advanced HCC","phase":"","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06416683","title":"Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma (ABCHCaen)","phase":"","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT06609863","title":"dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}